Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Trillions.
The item "Intagible-Assets" stands at 3.30 Trillion Japanese Yens as of 09/30/2025, the lowest value since 03/31/2019.
As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Intagible Assets" stands at 3.30 Trillion JPY. This represents a decrease of -3.60 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -12.50 percent compared to the value the year prior.
The 1 year change in percent is -12.50.
The 3 year change in percent is -21.20.
The 5 year change in percent is -14.93.
The 10 year change in percent is 270.68.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Intagible Assets | 905,699,262,464.00 |
![]() | Johnson & Johnson - Intagible Assets | 486,508,953,600.00 |
![]() | AbbVie Inc - Intagible Assets | 399,570,305,024.00 |
![]() | Roche Holding AG - Intagible Assets | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Intagible Assets | 280,205,508,085.11 |